| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.18 | 0.0004 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.21 | 0.0004 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.18 | 0.0004 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0004 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0005 |